The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
CISD2 inhibition overcomes resistance to sulfasalazine-induced ferroptotic cell death in head and neck cancer
Abstract
Sulfasalazine has been repurposed to induce ferroptotic cancer cell death via inhibition of xc--cystine/glutamate antiporter (xCT). However, cancer cells are capable of developing mechanisms to evade cell death. Therefore, we sought to determine the molecular mechanisms underlying resistance to sulfasalazine-induced ferroptosis in head and neck cancer (HNC). The effects of sulfasalazine and pioglitazone were tested in various HNC cell lines. The effects of these drugs and inhibition and overexpression of CISD2 gene were determined by evaluating viability, cell death, lipid ROS production, mitochondrial iron, and mouse tumor xenograft models. SAS induced ferroptotic cell death in HNC at different levels. CISD2 expression showed an association between its expression and ferroptosis resistance. CISD2 overexpression conferred resistance to ferroptosis by sulfasalazine. Silencing CISD2 gene rendered resistant HNC cells susceptible to sulfasalazine-induced ferroptosis, with increased levels of lipid ROS and mitochondrial ferrous iron. Pioglitazone induced over-accumulation of mitochondrial iron and ROS and sensitized resistant HNC cells to sulfasalazine treatment in vitro and in a mouse tumor-xenograft model. CISD2 inhibition overcomes HNC resistance to ferroptotic cell death induced by sulfasalazine via increased accumulation of mitochondrial ferrous iron and lipid ROS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.042 · Cited by 18,691
Regulation of Ferroptotic Cancer Cell Death by GPX4
Yang, W. S., SriRamaratnam, R., Welsch, M. E., Shimada, K., Skouta, R., Viswanathan, V. S., Cheah, J. H., Clemons, P. A., Shamji, A. F., Clish, C. B., et al. (2014) · Cell · doi:10.1016/j.cell.2013.12.010 · Cited by 7,713
Ferroptosis: process and function
Xie, Y., Hou, W., Song, X., Yu, Y., Huang, J., Sun, X., Kang, R., & Tang, D. (2016) · Cell Death & Differentiation · doi:10.1038/cdd.2015.158 · Cited by 3,727
Autophagy promotes ferroptosis by degradation of ferritin
Hou, W., Xie, Y., Song, X., Sun, X., Lotze, M. T., Zeh, H. J., Kang, R., & Tang, D. (2016) · Autophagy · doi:10.1080/15548627.2016.1187366 · Cited by 2,332
Dixon, S. J., Patel, D. N., Welsch, M., Skouta, R., Lee, E. D., Hayano, M., Thomas, A. G., Gleason, C. E., Tatonetti, N. P., Slusher, B. S., et al. (2014) · eLife · doi:10.7554/elife.02523 · Cited by 2,088
Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy
Mancias, J. D., Wang, X., Gygi, S. P., Harper, J. W., & Kimmelman, A. C. (2014) · Nature · doi:10.1038/nature13148 · Cited by 2,084
Ferroptosis is an autophagic cell death process
Gao, M., Monian, P., Pan, Q., Zhang, W., Xiang, J., & Jiang, X. (2016) · Cell Research · doi:10.1038/cr.2016.95 · Cited by 1,899
Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition
Hangauer, M. J., Viswanathan, V. S., Ryan, M. J., Bole, D., Eaton, J. K., Matov, A., Galeas, J., Dhruv, H. D., Berens, M. E., Schreiber, S. L., et al. (2017) · Nature · doi:10.1038/nature24297 · Cited by 1,799
Ishimoto, T., Nagano, O., Yae, T., Tamada, M., Motohara, T., Oshima, H., Oshima, M., Ikeda, T., Asaba, R., Yagi, H., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.01.038 · Cited by 1,192
NFS1 undergoes positive selection in lung tumours and protects cells from ferroptosis
Alvarez, S. W., Sviderskiy, V. O., Terzi, E. M., Papagiannakopoulos, T., Moreira, A. L., Adams, S., Sabatini, D. M., Birsoy, K., & Possemato, R. (2017) · Nature · doi:10.1038/nature24637 · Cited by 787
CISD1 inhibits ferroptosis by protection against mitochondrial lipid peroxidation
Yuan, H., Li, X., Zhang, X., Kang, R., & Tang, D. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.08.034 · Cited by 504
Inhibiting the system xC−/glutathione axis selectively targets cancers with mutant-p53 accumulation
Liu, D. S., Duong, C. P., Haupt, S., Montgomery, K. G., House, C. M., Azar, W. J., Pearson, H. B., Fisher, O. M., Read, M., Guerra, G. R., et al. (2017) · Nature Communications · doi:10.1038/ncomms14844 · Cited by 321
Antagonism of Beclin 1‐dependent autophagy by BCL‐2 at the endoplasmic reticulum requires NAF‐1
Chang, N. C., Nguyen, M., Germain, M., & Shore, G. C. (2010) · The EMBO Journal · doi:10.1038/emboj.2009.369 · Cited by 281
Sohn, Y.-S., Tamir, S., Song, L., Michaeli, D., Matouk, I., Conlan, A. R., Harir, Y., Holt, S. H., Shulaev, V., Paddock, M. L., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1313198110 · Cited by 216
Yoshikawa, M., Tsuchihashi, K., Ishimoto, T., Yae, T., Motohara, T., Sugihara, E., Onishi, N., Masuko, T., Yoshizawa, K., Kawashiri, S., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3609-t · Cited by 191
Sleire, L., Skeie, B. S., Netland, I. A., Førde, H. E., Dodoo, E., Selheim, F., Leiss, L., Heggdal, J. I., Pedersen, P.-H., Wang, J., et al. (2015) · Oncogene · doi:10.1038/onc.2015.60 · Cited by 175
Guan, J., Lo, M., Dockery, P., Mahon, S., Karp, C. M., Buckley, A. R., Lam, S., Gout, P. W., & Wang, Y.-Z. (2009) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0894-4 · Cited by 134
Sulfasalazine‐induced cystine starvation: Potential use for prostate cancer therapy
Doxsee, D. W., Gout, P. W., Kurita, T., Lo, M., Buckley, A. R., Wang, Y., Xue, H., Karp, C. M., Cutz, J., Cunha, G. R., et al. (2006) · The Prostate · doi:10.1002/pros.20508 · Cited by 124
Lo, M., Ling, V., Low, C., Wang, Y. Z., & Gout, P. W. (2010) · Current Oncology · doi:10.3747/co.v17i3.485 · Cited by 120
Establishment and Characterization of Nine New Head and Neck Cancer Cell Lines
Kim, S. Y., Chu, K., Lee, H. R., Lee, K., & Carey, T. E. (1997) · Acta Oto-Laryngologica · doi:10.3109/00016489709113477 · Cited by 90
Darash‐Yahana, M., Pozniak, Y., Lu, M., Sohn, Y., Karmi, O., Tamir, S., Bai, F., Song, L., Jennings, P. A., Pikarsky, E., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1612736113 · Cited by 84
A role for the CISD2 gene in lifespan control and human disease
Chen, Y., Wu, C., Kirby, R., Kao, C., & Tsai, T. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05619.x · Cited by 80
Activation of apoptosis in NAF-1-deficient human epithelial breast cancer cells
Holt, S. H., Darash‐Yahana, M., Sohn, Y. S., Song, L., Karmi, O., Tamir, S., Michaeli, D., Luo, Y., Paddock, M. L., Jennings, P. A., et al. (2015) · Journal of Cell Science · doi:10.1242/jcs.178293 · Cited by 64
Shitara, K., Doi, T., Nagano, O., Fukutani, M., Hasegawa, H., Nomura, S., Sato, A., Kuwata, T., Asai, K., Einaga, Y., et al. (2017) · Gastric Cancer · doi:10.1007/s10120-017-0720-y · Cited by 63
Integrated strategy reveals the protein interface between cancer targets Bcl-2 and NAF-1
Tamir, S., Rotem‐Bamberger, S., Katz, C., Morcos, F., Hailey, K. L., Zuris, J. A., Wang, C., Conlan, A. R., Lipper, C. H., Paddock, M. L., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1403770111 · Cited by 61
Wang, L., Ouyang, F., Liu, X., Wu, S., Wu, H., Xu, Y., Wang, B., Zhu, J., Xu, X., & Zhang, L. (2015) · Oncotarget · doi:10.18632/oncotarget.6302 · Cited by 58
Reichle, A., VOGT, T. M., Coras, B., et al. (2007) · Melanoma Research · doi:10.1097/cmr.0b013e3282f1d2c8 · Cited by 57
Liu, L., Xia, M., Wang, J., Zhang, W., Zhang, Y., & He, M. (2014) · Medical Oncology · doi:10.1007/s12032-014-0183-5 · Cited by 56
Interactions between mitoNEET and NAF-1 in cells
Karmi, O., Holt, S. H., Song, L., Tamir, S., Luo, Y., Bai, F., Adenwalla, A., Darash‐Yahana, M., Sohn, Y., Jennings, P. A., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175796 · Cited by 53
Tamir, S., Zuris, J. A., Agranat-Tamir, L., Lipper, C. H., Conlan, A. R., Michaeli, D., Harir, Y., Paddock, M. L., Mittler, R., Cabantchik, Z. I., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061202 · Cited by 50
Kole, L., Sarkar, M., Deb, A., & Giri, B. (2015) · Pharmacological Reports · doi:10.1016/j.pharep.2015.08.001 · Cited by 49
Yang, L., Hong, S., Wang, Y., He, Z., Liang, S., Chen, H., He, S., Wu, S., Song, L., & Chen, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.8150 · Cited by 34
Chen, B., Shen, S., Wu, J., Hua, Y., Kuang, M., Li, S., & Peng, B. (2015) · PubMed · Cited by 33
Ihle, N. T., Lemos, R., Schwartz, D. A., Oh, J., Halter, R. J., Wipf, P., Kirkpatrick, L., & Powis, G. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0714 · Cited by 31
Management of patients with inflammatory bowel disease and spondyloarthritis
Pouillon, L., Bossuyt, P. J., Vanderstukken, J., Moulin, D., Netter, P., Danese, S., Jouzeau, J., Lœuille, D., & Peyrin‐Biroulet, L. (2017) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2017.1377609 · Cited by 24
Cell death and restoration of TRAIL-sensitivity by ciglitazone in resistant cervical cancer cells
Plissonnier, M., Fauconnet, S., Bittard, H., Mougin, C., Rommelaere, J., & Lascombe, I. (2017) · Oncotarget · doi:10.18632/oncotarget.22632 · Cited by 20
Kong, M., & Hong, S. E. (2015) · Clinical and Experimental Otorhinolaryngology · doi:10.3342/ceo.2015.8.4.416 · Cited by 18
Pathway analysis of genome-wide association study on serum prostate-specific antigen levels
Ge, Y., Xu, Z., Xu, L., Peng, Y., Zhao, Y., Xin, H., Wu, R., Tan, S., Song, Q., Wu, J., et al. (2014) · Gene · doi:10.1016/j.gene.2014.08.044 · Cited by 16
Cited by
Ferroptosis: molecular mechanisms and health implications
Tang, D., Chen, X., Kang, R., & Kroemer, G. (2021) · Cell Research · doi:10.1038/s41422-020-00441-1 · Cited by 4,256
Ferroptosis: past, present and future
Li, J., Cao, F., Yin, H.-L., Huang, Z.-J., Lin, Z.-T., Mao, N., Sun, B., & Wang, G. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-2298-2 · Cited by 4,171
Broadening horizons: the role of ferroptosis in cancer
Chen, X., Kang, R., Kroemer, G., & Tang, D. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-00462-0 · Cited by 2,897
Targeting Ferroptosis as a Vulnerability in Cancer
Lei, G., Zhuang, L., & Gan, B. (2022) · Nature reviews. Cancer · doi:10.1038/s41568-022-00459-0 · Cited by 2,252
Reactive Oxygen Species-Induced Lipid Peroxidation in Apoptosis, Autophagy, and Ferroptosis
Su, L.-J., Zhang, J.-H., Gomez, H., Murugan, R., Hong, X., Xu, D., Jiang, F., & Peng, Z.-Y. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/5080843 · Cited by 2,166
Metadata
- Authors
- Kim, E. H., Shin, D., Lee, J., Jung, A. R., & Roh, J.-L.
- Venue
- Cancer Letters
- Publisher
- Elsevier BV
- Published
- 2018-09
- Volume
- 432
- Pages
- 180-190
- ISSN
- 0304-3835 (ISSN-L)
- OpenAlex
- W2808878881
- Cited by
- 261
- References
- 38
- FWCI
- 12.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.